rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nomad Power Solutions, Inc.

NMAD · Nasdaq

Health CareBiotechnologyNot moving yetData-Center Infrastructure

NMAD stood above a rising 150-day average in 20 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 23.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 13
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
18 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders18+5 on the quarter
New · exited9 · 4
Reported value$14.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Legacy Wealth Managment, LLCnew · filed 13 Aug 2026600,669$4.5M+600,669
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026555,476$4.1M+505,997+1022.7%
SCOTIA CAPITAL INC.unchanged · filed 11 Aug 2026283,162$2.1M00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026143,036$1.1M+84,184+143.0%
BlackRock, Inc.new · filed 7 Aug 202675,958$564K+75,958
STATE STREET CORPadded · filed 7 Aug 202675,096$557K+57,700+331.7%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202667,280$499K+32,246+92.0%
Federation des caisses Desjardins du Quebecreduced · filed 14 Aug 202638,130$283K-26,357−40.9%
NORTHERN TRUST CORPnew · filed 13 Aug 202627,655$205K+27,655
Ethos Financial Group, LLCunchanged · filed 7 Aug 202624,808$100K00.0%
30 Jun 2023 – 30 Jun 2026
51117Jun 23Mar 24Dec 24Sep 25Jun 26

Everyone who traded it

Geordan Garrett Pursglove Company insiderCEO and Chairman of the Board · last 1 Jul 20260 · 0
Guy Warren Primus Company insiderDirector · last 1 Jul 20260 · 0
Jason David Sawyer Company insiderDirector · last 1 Jul 20260 · 0
Lourdes Felix Company insiderDirector · last 1 Jul 20260 · 0
Michael Andrew Holloway Company insiderDirector · last 1 Jul 20260 · 0
Peter Stazzone Company insiderChief Financial Officer · last 1 Jul 20260 · 0
Stuart D. Porter Company insiderDirector · last 29 May 20260 · 0
Regina Brown Company insiderDirector · last 30 Jun 20251 · 0
Rene Bernards Company insiderDirector · last 30 Jun 20257 · 0
Stephen J. Forman Company insiderDirector · last 30 Jun 20252 · 0
Yun Yen Company insiderDirector · last 30 Jun 20251 · 0
Der Baan Bastiaan Jeroen Van Company insiderPresident, CEO & Vice Chairman · last 3 Oct 20233 · 0

Same industry

MRNA ModernaLeading+168%
IOVA Iovance BiotherapeuticsLeading+134%
ABCL AbCellera BiologicsLeading+62%
ENTX Entera BioLeading+53%
HALO Halozyme TherapeuticsLeading+48%
XERS Xeris Biopharma HoldingsLeading+42%
XNCR XencorLeading+41%
HELP Helus PharmaLeading+37%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-44.8%
Share count trendFY 2025 · to 31 Mar 202632.2%

Analyst forecasts

No analyst forecasts yet.